Blood & Tissue Collection Centers
Guidance
- FDA – Revised Recommendations for Reducing the Risk of Zika Virus Transmission by Blood and Blood Components (August 26, 2016) [PDF – 17 pages]
- FDA – Donor Screening Recommendations to Reduce the Risk of Transmission of Zika Virus by Human Cells, Tissues, and Cellular and Tissue-Based Products [PDF – 10 pages]
Additional Resources
- Zika Virus Response Updates from FDA
- Cost Projections for Implementation of Safety Interventions to Prevent Transfusion-Transmitted Zika Virus Infection in the United States
- Investigation Toolkit: Transfusion-transmitted Infections (TTI)
- Investigation Toolkit: Transplant-Transmitted Infection
- MMWR: Survey of Blood Collection Centers and Implementation of Guidance for Prevention of Transfusion-Transmitted Zika Virus Infection – Puerto Rico, 2016
- AABB – American Association of Blood Banks
- Use of Blood Donor Screening Data to Estimate Zika Virus Incidence, Puerto Rico, April—August 2016 (EID)
CDC is working with our partners to learn more about Zika and blood/tissue safety
- AABB – American Association of Blood Banks
- FDA – US Food and Drug Administration
- State and territorial health departments
- Blood collection centers
- HCT/P collection centers
- Page last reviewed: June 19, 2017
- Page last updated: June 19, 2017
- Content source: